Jacquelyn Gray

A national clinical trial has found non-efavirenz antiretroviral therapy effective as a first-line treatment, which is good news for patients with HIV who are ineligible to usea the common drug.

From 2001 to 2010, the infection rate of a particular intestinal "superbug" has doubled, with increases in mortality rates and length of hospital stays reflecting this trend.

Hoping their discovery will lead to novel treatments, University of Florida researchers have successfully manufactured the human norovirus in a cell culture dish.

A team of researchers at George Washington University has reported that next-generation sequencing of sputum samples taken from patients in the intensive care unit can accurately identify the strain of ventilator-associated pneumonia a patient is infected with.

Despite previous research suggesting HIV patients have an increased likelihood of suffering from a heart attack, kidney failure, or cancer, Johns Hopkins Bloomberg School of Public Health investigators showed the age they encounter these conditions were similar to their uninfected counterparts.

While half of all HIV/AIDS patients are African American, they only comprise 30% of those enrolled in clinical trials on the disease.

Although it is widely understood that hepatitis B virus (HBV) and hepatitis C virus (HCV) are the leading causes of liver cirrhosis and liver cancer, an alarming number of HBV and HCV carriers have unhealthy habits that result in poor liver health.